Debra Patt, MD, PhD, MBA

ASCO 2026 data show ePRO remote symptom monitoring cuts ER visits and costs, enabling faster toxicity detection and safer community cancer care.

OncoPRO unites oncology practices to streamline ePRO remote symptom monitoring, improving enrollment, workflow integration, and change management through shared implementation strategies.

ASCO 2026 data show ePRO symptom tracking keeps cancer patients on therapy longer, cuts hospitalizations and costs, and may boost survival.

Real-world ASCO 2026 data show ePRO-based remote monitoring helps catch metastatic cancer treatment symptoms earlier, improving toxicity control and reducing hospitalizations.

Community oncology faces consolidation, policy shocks, AI adoption, and advanced therapies—learn what leaders say to protect local cancer care access.

Debra A. Patt, MD, PhD, MBA, discusses a study of digital health systems used at Texas Oncology locations and how it helps with remote communication between patients with cancer and clinicians.

Debra Patt, MD, MPH, MBA, medical oncologist, director of Public Policy, Texas Oncology, director of Health Care Informatics, McKesson Specialty Health and The US Oncology Network, discusses the challenges that medical oncologists will face due to health care reform.